|
|
|||||||||||||||||||||||
Article Navigation
|
All about quercitinby: John Gibb In this article, we'll explain all about quercitin that you need to know. Quercitin, a bioflavonoid ( a type of nutrient that is found in some fruits and green, leafy vegetables, amongst other things such as teas and beans) can be a great asset to your health when taken as a supplement to a healthy diet. Bioflavoniods are the nutrients necessary to maintaining the health of your skin. This is because they help to create collagen, the substance that keeps our skin firm and healthy. Therefore, a lack of collagen can lead to wrinkles and sagginess. Quercitin has also been shown to help the body improve the health of its capillaries and connective tissues. Due to this, quercitin has been linked to helping to alleve bruising, unsightly varicose veins, fragile cappilaries, and edema. Also, good news for allergies! Quercitin has been known to block the release of histamine, which may help aid conditions brought on by allergies. After testing at the Mayo clinic, quercitin was also shown to be useful in helping to treat or prevent prostate cancer. In the findings of the Mayo Clinic study about quercitin, Mayo Clinic researcher Nianzeng Xing, Ph.D stated that "Our laboratory results showed quercitin blocks the androgen activity in androgen-responsive human prostate cancer cell lines." He then followed this statement by asserting that "By blocking the androgen activity, the growth of prostate cancer cells can be prevented or stopped." While this research doesnt prove quercitin will actually truly benefit men with prostate cancer or those at risk, it definitely shows promise as a preliminary study. While there is not a recommended daily allowance, or RDA, of quercitin, studies have indicated that toxicity with quercitin is largely a non issue. However, a dosage of somewhere between 50 mgs and 150 mgs per day is a reasonable dose, and using mega-doses is not recommended. If you are pregnant or nursing, it would be a good idea to speak with your physician before beginning taking this supplement. Latest Cancer News:FDA panel votes against Xgeva for prostate cancer A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients Breast cancer kills older women more often NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed with a certain type of breast cancer, those over 75 years old were 63 percent more likely to die of the cancer than women younger than 65. "I suspect it's ... Breast cancer charity chases Komen defectors As a prominent breast cancer researcher and activist, Susan Love is no stranger to the Susan G. Komen Foundation. Love runs a breast cancer research foundation that bears her name, and she organized the Army of Women , more than 360,000 women to whom breast cancer researchers can blast out requests for subjects. But the Komen Foundation is so entrenched in the world of breast cancer fundraising ... A Better Way to Spend Breast Cancer Funds? We must move breast cancer advocacy to the next level, beyond screening for cancers that are already there, even beyond the cure, to finding the cause, writes Dr. Susan Love. Cancer-hit cricketer Yuvraj vows to return stronger India's cancer-stricken World Cup hero Yuvraj Singh has vowed to return "stronger than ever" to competitive cricket, saying he was responding well to treatment in the United States. Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 NEW YORK, Feb. 8, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 http://www.reportlinker.com/p0657184/Doxil/Caelyx-Ovarian-Cancer---Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyDoxil/Caelyx ... Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines NEW YORK, Feb. 8, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines http://www.reportlinker.com/p0284988/Triple-Analysis-Lung-Cancer-Angiogenesis-and-Cancer-Vaccines.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationThis ... Marian Regional Medical Center Receives CEO Cancer Gold Standard Accreditation The CEO Roundtable on Cancer recently accredited Marian Regional Medical Center with the CEO Cancer Gold Standard? recognizing the hospital?s efforts to reduce the risk of cancer f Breast Cancer Drug May Weaken Bones, Study Finds TUESDAY, Feb. 7 (HealthDay News) -- A drug used to prevent breast cancer in women at high risk for the disease appears to cause bone loss in some postmenopausal women, a new study finds. Marc Garnick Answers 6 Key Questions about Prostate Cancer Marc Garnick Answers 6 Key Questions about Prostate Cancer Insight: Komen charity under microscope for funding, science - Reuters
|
||||||||||||||||||||||
Copyright © 2006 CancerAdvice.org